___

• 1. Smolinski KN, Yan AC. Hemangiomas of Infancy: Clinical and biological characteristics. Clin Pediatr 2005; 44:747-66.
• 2. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48:477-96.
• 3. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Ped Dermatol 2005; 22:383-406.
• 4. Esterly NB. Hemangiomas. In: Harper J, Oranje A, Prose N (eds). Texbook of Pediatric Dermatology. 1st edition. Slovenia. Blackwell Science Ltd; 2002.p. 997-1017.
• 5. Buckmiller LM. Update on hemangiomas and vascular malformations. Curr Opin Otolaryngol Head Neck Surg. 2004; 12:476-87.
• 6. Gampper TJ, Morgan RF. Vascular anomalies-Hemangiomas. Plast Reconstr Surg 2002; 110:572-85.
• 7. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: An extradiagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005; 58:348-52.
• 8. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1997; 13:375-423.
• 9. Powell J. Update on hemangiomas and vascular malformations. Curr Opin Pediatr 1999 Oct; 11(5):457-63.
• 11. Metry DW, Haggstrom AN, Drolet BA , et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006; 140:975-86.
• 12. Ceisler EJ, Santos L, Blei F. Periorbital hemangiomas: what every physician should know. Pediatr Dermatol 2004; 21:1-9.
• 13. Schwartz SR, Blei F, Ceisler E, et al. Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AAPOS 2006; 10:262-8.
• 14. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics 2006; 118:882-7.
• 15. Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989; 83:977-80.
• 16. Prokurat A, Kluge P, Chrupek M, et al. Hemangioma of the liver in children: Proliferating vascular tumor or congenital vascular malformation? Med Pediatr Oncol 2002; 39:4524-9.
• 17. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Eng J Med 2000; 343:185-9.
• 18. Maguiness S, Guenter L. Kasabach-Merritt Syndrome. J Cutan Med Sur 2002; 6:335-9.
• 19. Burrows PA, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies. Pediatr Radiol 2001; 31:533-45.
• 20. Mazoer E Enjolras O, Laurian C, et al Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haem 2000; 24:243-51.
• 21. Frevel T, Rabe H, Ückert F, Harms E. Giant cavenous haemangioma with Kasabach-Meritt syndrome:a case report and review.Eur J Pediatr 2002; 161:43-246.
• 22. Hesselmann S, Micke O, Marquardt T, et al. Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha. Br J Radiol 2002; 75:180-4.
• 23. Enjolras O, Riche MC,Merland JJ, et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990; 85:491-8.
• 24. Brasanac D, Janic D, Boricic I, et al. Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. Pathol Int 2003 Sep; 53:627-31.
• 25. Deb G, Jenkner A, De Sio L, et al. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon. Med Pediatr Oncol 1997; 28:358-61.
• 26. Wananukul S, Nuchprayoon I, Seksarn P. Treatment of KasabachMerritt syndrome : a stepwise regimen of prednisolone , dipyridamole and interferon. Int J Dermatol 2003; 42:741-8.
• 27. Moore J, Lee M, Garzon M, et al. Effective therapy of a vascular tumor of infancy with vincristine. J Pediatr Surg 2001; 36:1273-6.
• 28. Fledelius HC, Illum N, Jensen H, Prause JU. Interferon-alfa treatment of facial infantile haemangiomas with emphasis on the sightthreatening varieties. A clinical series. Acta Ophthalmol Scand 2001; 79:370-3.
• 29. Michaud AP, Bauman NM, Burke DK, et al. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004; 114:1231-6.